Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
…ical stage NKG2D-based linear CAR. The trial hypothesis is that LEU011, combined with lymphodepleting chemotherapy (LDC), will be safe…
…primary objectives are to assess the safety and tolerability of COM503 as monotherapy and in combination with zimberelimab and identif…
…3W IV starting day 1, Trans-arterial Tirapazamine embolization (TATE) on Days 8, 29 and on demand to achieve optimal tumor necrosis …
…minary antitumor activity across broad cancer types.Conclusions AWT020 demonstrates a manageable safety profile and promising early an…
…hemotherapy demonstrated significantly improved PFS compared to bevacizumab plus chemotherapy in the primary analysis. While OS favored the…
…), demonstrating substantial combinatorial activity.Conclusions HDM2021 has demonstrated a potent and effective CBL-B inhibitor, exhibi…
…cose(FDG), followed one day later by a single i.v. injection of [89Zr]-αCD47 and serial PET/CT imaging. Terminal ex-vivo biodistribution ana…
…rgy with cancer vaccines.Methods Two small molecule inhibitors, TT-10 and TT-4 (Portage Biotech) targeting type A2A and A2B receptors…
… total, we sequenced 13,914 TILs from EO771 tumors treated with ICI monotherapy or dual checkpoint blockade. By unsupervised cluste…
…ment (TME). 1 Therefore, we propose a combination approach with [67Cu]Cu-LLP2A, a radiopharmaceutical therapy (RPT) targeting the very late an…
…fficacy, including immune checkpoint inhibitors (ICIs), such as anti-PD-1.11 To overcome the obstacle of MDSCs, our laboratory developed …